[{"Assets_0_Q2_USD":175696000.0,"CommonStockSharesOutstanding_0_Q2_shares":98307859.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-29905000.0,"NetIncomeLoss_1_Q2_USD":-16682000.0,"NetIncomeLoss_2_Q2_USD":-34567000.0,"StockholdersEquity_0_Q2_USD":151269000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]